ELMD
Electromed Inc.

727
Mkt Cap
$196.12M
Volume
180.00
52W High
$30.73
52W Low
$17.73
PE Ratio
23.07
ELMD Fundamentals
Price
$23.70
Prev Close
$24.07
Open
$23.84
50D MA
$27.59
Beta
0.64
Avg. Volume
41,307.55
EPS (Annual)
$0.8455
P/B
4.32
Rev/Employee
$355,555.56
$180.94
Loading...
Loading...
News
all
press releases
Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed
Intuitive Surgical, Edwards and Electromed tap GenAI tailwinds as AI healthcare spending surges, despite industry under performance.
Zacks·6d ago
News Placeholder
More News
News Placeholder
3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes
ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.
Zacks·7d ago
News Placeholder
Here is Why Growth Investors Should Buy Electromed (ELMD) Now
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·18d ago
News Placeholder
Electromed, Inc. (ELMD) Q2 Earnings and Revenues Top Estimates
Electromed (ELMD) delivered earnings and revenue surprises of +20.76% and +4.40%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20d ago
News Placeholder
AbbVie (ABBV) Tops Q4 Earnings and Revenue Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of +2.02% and +1.58%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·26d ago
News Placeholder
5 Highly Efficient Stocks That Stand Out on Key Profitability Ratios
United Natural Foods leads a screen of five efficient stocks that beat peers on key ratios, highlighting names investors may consider for stronger returns.
Zacks·2mo ago
News Placeholder
3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD)
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·3mo ago
News Placeholder
Wall Street Analysts See a 36.98% Upside in Electromed (ELMD): Can the Stock Really Move This High?
The consensus price target hints at a 37% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·3mo ago
News Placeholder
Best Momentum Stock to Buy for Nov. 17th
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
Zacks·3mo ago
News Placeholder
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Zacks·4mo ago
<
1
2
...
>

Latest ELMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.